{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:33:25Z","timestamp":1782225205084,"version":"3.54.5"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2002,7,23]]},"DOI":"10.1212\/wnl.59.2.251","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:03:50Z","timestamp":1336917830000},"page":"251-255","source":"Crossref","is-referenced-by-count":202,"title":["Lamotrigine clearance during pregnancy"],"prefix":"10.1212","volume":"59","author":[{"given":"T. A.","family":"Tran","sequence":"first","affiliation":[{"name":"From MINCEP Epilepsy Care (Drs. Tran, Leppik, and Blesi), Department of Neurology (Drs. Tran, Leppik, and Sathanandan), and College of Pharmacy (Drs. Leppik and Remmel), University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. E.","family":"Leppik","sequence":"additional","affiliation":[{"name":"From MINCEP Epilepsy Care (Drs. Tran, Leppik, and Blesi), Department of Neurology (Drs. Tran, Leppik, and Sathanandan), and College of Pharmacy (Drs. Leppik and Remmel), University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Blesi","sequence":"additional","affiliation":[{"name":"From MINCEP Epilepsy Care (Drs. Tran, Leppik, and Blesi), Department of Neurology (Drs. Tran, Leppik, and Sathanandan), and College of Pharmacy (Drs. Leppik and Remmel), University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. T.","family":"Sathanandan","sequence":"additional","affiliation":[{"name":"From MINCEP Epilepsy Care (Drs. Tran, Leppik, and Blesi), Department of Neurology (Drs. Tran, Leppik, and Sathanandan), and College of Pharmacy (Drs. Leppik and Remmel), University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Remmel","sequence":"additional","affiliation":[{"name":"From MINCEP Epilepsy Care (Drs. Tran, Leppik, and Blesi), Department of Neurology (Drs. Tran, Leppik, and Sathanandan), and College of Pharmacy (Drs. Leppik and Remmel), University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","unstructured":"Levy RH Thummel KE Unadkat JD. General principles: Drug absorption distribution and elimination. In: Levy RH Mattson RH Meldrum BS eds. Antiepileptic drugs 4th ed. New York: Raven Press 1995: 13\u201330."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1991.tb05253.x"},{"key":"e_1_3_2_4_2","first-page":"552","volume":"26","year":"1985","unstructured":"Levy RH, Yerby MS. Effects of pregnancy on antiepileptic drug utilization. Epilepsia . 1985; 26 (suppl 1): 552\u2013557.","journal-title":"Epilepsia"},{"key":"e_1_3_2_5_2","first-page":"126","volume":"70","year":"1981","unstructured":"McElany JC. Interaction of phenytoin with antacid constituents and kaolin. Br J Pharmacol . 1981; 70: 126\u2013127.","journal-title":"Br J Pharmacol"},{"key":"e_1_3_2_6_2","unstructured":"Bardy AH Teramo K Hiilesmaa VK. Apparent plasma clearances of phenytoin phenobarbital primidone and carbamazepine during pregnancy: results of a prospective Helsinki study. In: Janz D Bossi L Dam M et al. eds. Epilepsy pregnancy and the child. New York: Raven Press 1982: 141\u2013145."},{"key":"e_1_3_2_7_2","first-page":"264","volume":"212","year":"1979","unstructured":"Stock B, Dean M, Levy G. Serum protein binding of drugs during and after pregnancy in rats. J Pharmacol Exp Ther . 1979; 212: 264\u2013268.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.158"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(87)90053-2"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1977.tb02145.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198403000-00006"},{"key":"e_1_3_2_12_2","first-page":"240","volume":"3","year":"1988","unstructured":"Leppik IE, Rask CA. Pharmacokinetics of antiepileptic drugs during pregnancy. Semin Neurol . 1988; 3: 240\u2013246.","journal-title":"Semin Neurol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(87)90096-9"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0090-9556(25)08481-8","volume":"24","year":"1996","unstructured":"Bajpai M, Roskos LK, Shen DD, Levy RH. Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite. Drug Metab Dispos . 1996; 24: 1401\u20131403.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0022-3565(25)11424-9","volume":"260","year":"1992","unstructured":"Magdalou J, Herber R, Bidault R, Siest G. In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. J Pharmacol Exp Ther . 1992; 260: 1166\u20131173.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199911)46:5<739::AID-ANA9>3.0.CO;2-2"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073897012001041"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0090-9556(25)06536-5","volume":"23","year":"1995","unstructured":"Green MD, Bishop WP, Tephly TR. Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. Drug Metab Dispos . 1995; 23: 299\u2013302.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01489.x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb00232.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.4.519"},{"key":"e_1_3_2_22_2","first-page":"246.","volume":"41","year":"2000","unstructured":"Sathanandan ST, Blesi K, Tran TA, Leppik IE. Lamotrigine clearance increases markedly during pregnancy. Epilepsia . 2000; 41 (suppl 7): 246.","journal-title":"Epilepsia"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/000456329503200611"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Clearance concepts. In: Gibaldi M Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker 1982:319\u2013323.","DOI":"10.1201\/b14095-9"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200110000-00008"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0022-5347(25)00231-9","volume":"241","year":"1987","unstructured":"Walle T, Walle UK, Cowart TD, Conradi EC, Gaffney TE. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites. J Pharmacol Exp Ther . 1987; 241: 928\u2013933.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.193"},{"key":"e_1_3_2_29_2","unstructured":"Gram L. Potential antiepileptic drugs: lamotrigine. In: Levy R Mattson R Meldrum B et al. eds. Antiepileptic drugs. 3rd ed. New York: Raven Press 1989: 947\u2013953."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(91)90065-T"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197925174"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050234"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.59.2.251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T23:03:10Z","timestamp":1743116590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.59.2.251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,23]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,7,23]]}},"alternative-id":["10.1212\/WNL.59.2.251"],"URL":"https:\/\/doi.org\/10.1212\/wnl.59.2.251","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,23]]}}}